Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BOIRON : 2017 first quarter activity



2017 FIRST QUARTER

BOIRON ACTIVITY

 (Unaudited data)


 



in thousands of euros
2016
2017
Variation at current exchange rates
Variation at constant exchange rates


France
90,494
97,134
+7.3%
+7.3%


Europe (excluding France)
43,685
40,418
-7.5%
-11.9%


North America
16,064
18,179
+13.2%
+8.9%


Other countries
3,846
4,532
+17.8%
+12.8%


Group total
154,089
160,263
+4.0%
+2.2%





in thousands of euros
2016
2017
Variation at current exchange rates
Variation at constant exchange rates


Non-proprietary Homeopathic Medicines
80,147
81,016
+1.1%
+0.9%


OTC Specialties
73,743
78,968
+7.1%
+3.5%


Other
199
279
+40.2%
+40.2%


Group total
154,089
160,263
+4.0%
+2.2%


 


HIGHLIGHTS OF THE FIRST QUARTER


The turnover in the first quarter of 2017 grew by 4% in comparison to the first quarter of 2016 (+2.2% at constant exchange rates) due to the favorable impact of the exchange rates of the rouble and the US dollar.

This growth concerns most countries with the exception of Russia, Romania and Spain.


On April 7, 2017, the Laboratoires Boiron and the Laboratoires Arkopharma have finalized the acquisition by Boiron of the Laboratoire Ferrier, a subsidiary of Arkopharma.


For the current year, we remain cautious about the evolution of sales and results.

Our company carries on the development of homeopathy in the world with the same determination.


 


Our next updates:

May 18, 2017 at 10:30 am, at BOIRON headquarters, 2 avenue de l'Ouest Lyonnais, 69510 MESSIMY - FRANCE: Mixed Shareholders' Meeting.

June 2, 2017: after approval by the Mixed Shareholders' Meeting, payment of the proposed dividend (€1.60 per share).

July 20, 2017: after the close of the stock market, publication of the sales on June 30, 2017.

Person responsible for financial information: Christian Boiron

Contact for financial information: Véronique Bouscayrol

Investor relations: +33 (0) 4.78.45.63.43 - e-mail : [email protected]

ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA

The group's financial information is online at: www.boironfinance.com





Regulated information

Quaterly financial disclosure:

- First Quarter Information

Full and original press release in PDF:


https://www.actusnews.com/documents_communiques/ACTUS-0-48175-cp-boiron-200417.pdf


Receive by email the next press releases of the company by registering on
www.actusnews.com, it's free



Source: Actusnews

Boiron S.A. Stock

€34.00
0.740%
The Boiron S.A. stock is trending slightly upwards today, with an increase of €0.25 (0.740%) compared to yesterday's price.

Like: 0
Share

Comments